Ginette Serrero Selected Research

Progranulins

5/2022	Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients.
11/2021	Serum GP88 as a predictive biomarker for hepatocellular carcinoma in patients with viral hepatitis C after direct-acting antiviral agents.
5/2021	GP88/PGRN Serum Levels Are Associated with Prognosis for Oral Squamous Cell Carcinoma Patients.
4/2021	Anti-progranulin/GP88 antibody AG01 inhibits triple negative breast cancer cell proliferation and migration.
1/2021	Progranulin depletion inhibits proliferation via the transforming growth factor beta/SMAD family member 2 signaling axis in Kasumi-1 cells.
1/2021	Clinicopathological characteristics and outcomes of gastrointestinal stromal tumors with high progranulin expression.
1/2021	Progranulin/GP88, A Complex and Multifaceted Player of Tumor Growth by Direct Action and via the Tumor Microenvironment.
1/2020	Association of Serum Progranulin Levels With Disease Progression, Therapy Response and Survival in Patients With Metastatic Breast Cancer.
1/2020	Prognostic Value of Progranulin in Patients with Colorectal Cancer Treated with Curative Resection.
12/2019	Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer Patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ginette Serrero Research Topics

Disease

24	Neoplasms (Cancer) 05/2021 - 01/2003
14	Carcinogenesis 11/2021 - 08/2003
14	Breast Neoplasms (Breast Cancer) 04/2021 - 08/2003
5	Prostatic Neoplasms (Prostate Cancer) 05/2022 - 03/2009
4	Ductal Carcinoma 08/2016 - 07/2006
3	Carcinoma (Carcinomatosis) 05/2018 - 05/2009
2	Inflammation (Inflammations) 01/2021 - 10/2017
2	Lymphoma (Lymphomas) 05/2018 - 10/2017
2	Neoplasm Metastasis (Metastasis) 05/2018 - 08/2003
2	Multiple Myeloma 01/2006 - 06/2003
1	Hepatitis C 11/2021
1	Hepatocellular Carcinoma (Hepatoma) 11/2021
1	Chronic Hepatitis C 11/2021
1	Triple Negative Breast Neoplasms 04/2021
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2021
1	Frontotemporal Dementia (Semantic Dementia) 01/2021
1	Disease Progression 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 05/2018
1	Cognitive Dysfunction 05/2018
1	Neuromyelitis Optica (Devic's Disease) 01/2017
1	Multiple Sclerosis 01/2017
1	Lung Neoplasms (Lung Cancer) 11/2016
1	Rheumatoid Arthritis 10/2014
1	Osteoarthritis 10/2014
1	Chronic Obstructive Pulmonary Disease (COPD) 09/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 05/2009
1	Transitional Cell Carcinoma 05/2009
1	Glioblastoma (Glioblastoma Multiforme) 05/2009
1	Kidney Neoplasms (Kidney Cancer) 05/2009
1	Wounds and Injuries (Trauma) 03/2009
1	Prostatic Intraepithelial Neoplasia 02/2004
1	Adenocarcinoma 02/2004
1	Ovarian Epithelial Carcinoma 01/2003
1	Ovarian Neoplasms (Ovarian Cancer) 01/2003

Drug/Important Bio-Agent (IBA)

36	ProgranulinsIBA 05/2022 - 01/2003
13	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2021 - 01/2003
8	Glycoproteins (Glycoprotein)IBA 11/2021 - 09/2004
6	Biomarkers (Surrogate Marker)IBA 05/2022 - 03/2009
5	Biological ProductsIBA 11/2021 - 08/2003
4	EnzymesIBA 11/2021 - 09/2014
4	Estrogens (Estrogen)FDA Link 11/2016 - 03/2004
4	Estrogen ReceptorsIBA 08/2016 - 03/2004
3	Proteins (Proteins, Gene)FDA Link 05/2022 - 12/2019
2	ParaffinIBA 01/2018 - 02/2012
2	Messenger RNA (mRNA)IBA 05/2009 - 03/2009
2	Tamoxifen FDA LinkGeneric 09/2004 - 03/2004
1	Antiviral Agents (Antivirals)IBA 11/2021
1	asunaprevirIBA 11/2021
1	daclatasvirIBA 11/2021
1	Protein Kinases (Protein Kinase)IBA 04/2021
1	prostaglandin F2alpha receptorIBA 01/2021
1	SaporinsIBA 01/2021
1	AntibodiesIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Extracellular Matrix ProteinsIBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 09/2020
1	Formaldehyde (Formol)FDA Link 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2015
1	ImmunosorbentsIBA 10/2014
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2014
1	Progesterone Receptors (Progesterone Receptor)IBA 02/2012
1	Aromatase InhibitorsIBA 06/2011
1	Letrozole (Femara)FDA LinkGeneric 06/2011
1	Aromatase (CYP19)IBA 06/2011
1	Mitogen-Activated Protein KinasesIBA 05/2009
1	Small Interfering RNA (siRNA)IBA 05/2009
1	AndrogensIBA 03/2009
1	Oncogene Proteins (Oncogene Protein)IBA 07/2006
1	Trastuzumab (Herceptin)FDA Link 07/2006
1	Pharmaceutical PreparationsIBA 01/2006
1	AgarIBA 01/2006
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2006
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2004
1	Estradiol (Delestrogen)FDA LinkGeneric 03/2004
1	RNA (Ribonucleic Acid)IBA 01/2003
1	GranulinsIBA 01/2003

Therapy/Procedure

8	Therapeutics 05/2022 - 08/2003
1	Aftercare (After-Treatment) 11/2021
1	Drug Therapy (Chemotherapy) 11/2016
1	Biological Therapy 11/2016
1	Precision Medicine 11/2016